Results 51 to 60 of about 2,355 (177)

Prolonged ruxolitinib cream treatment for vitiligo among patients with no or limited response in the first 6 months

open access: yes
Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 8, Page e715-e718, August 2026.
Albert Wolkerstorfer   +10 more
wiley   +1 more source

Systemic Absorption and Pharmacokinetics of Five Novel Topical Dermatologic Agents: A Review

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 385-393, June 2026.
ABSTRACT In recent years, innovative topical medications with novel mechanisms of action have emerged to treat common dermatologic conditions such as acne, atopic dermatitis, vitiligo, and actinic keratoses. These molecularly targeted therapies offer improved safety and tolerability compared to traditional options like corticosteroids.
Mary Dyson   +4 more
wiley   +1 more source

Abnormal pigmentation within cutaneous scars: A complication of wound healing

open access: yesIndian Journal of Plastic Surgery, 2012
Abnormally pigmented scars are an undesirable consequence of cutaneous wound healing and are a complication every single individual worldwide is at risk of.
Sarah Chadwick   +2 more
doaj   +1 more source

Immunotherapy‐Related Cutaneous Toxicities in Melanoma: A Dermoscopic Perspective

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 402-414, June 2026.
Dermoscopy serves as a valuable tool in the everyday dermatological and oncological practice for melanoma patients, allowing for the prompt identification of immune‐related cutaneous toxicities and guiding clinicians toward appropriate therapeutic decisions.
Grażyna Kamińska‐Winciorek   +3 more
wiley   +1 more source

Omalizumab treatment for chronic spontaneous urticaria coinciding with marked improvement of vitiligo: a case report

open access: yesFrontiers in Medicine
We report the case of a 49-year-old female patient with a history of hyperthyroidism and long-standing vitiligo for over two decades, who presented with a 6-year history of chronic spontaneous urticaria (CSU) refractory to conventional antihistamine ...
Songfa Lin   +4 more
doaj   +1 more source

Non-Cultured Melanocyte–Keratinocyte Transplantation for Stable Vitiligo

open access: yesZagazig University Medical Journal
Background: Vitiligo is a chronic depigmenting disorder with complex pathogenesis, often requiring surgical intervention in stable cases. Autologous non-cultured melanocyte–keratinocyte transplantation (MKTP) has emerged as an effective therapeutic ...
Soheir Ghonemy   +2 more
doaj   +1 more source

Non Trypsinized versus Trypsinized Non-Cultured Epidermal Cell Graft in the Treatment of Stable Vitiligo [PDF]

open access: yesZagazig University Medical Journal
Background: Surgical management is the mainstay of treatment for stable vitiligo. Non-cultured trypsinized epidermal cell suspension (NCES-T) and non-cultured non-trypsinized epidermal cell grafting (NCES-NT, Jodhpur technique) are commonly used ...
Manal Ibrahim   +2 more
doaj   +1 more source

The Value of Sequential Dermoscopy in Avoiding Unnecessary Re‐Excisions of Recurrent Nevi

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 7, Page e969-e971, July 2026.
Ina Sotiri   +6 more
wiley   +1 more source

Smashed skin grafting in stable vitiligo: Efficacy and safety

open access: yesPigment International
Background: Vitiligo is a common skin disorder that entails cosmetic disfigurement due to depigmentation and carries a social stigma. Smash grafting is an easy-to-master surgical treatment modality for stable vitiligo that has failed to respond to other ...
Manjit Kaur, Suresh Kumar Malhotra
doaj   +1 more source

Topical mycophenolate mofetil in the treatment of vitiligo: a pilot study

open access: yesDermatology Practical & Conceptual, 2017
Background: Vitiligo is a multifactorial disease that is characterized by circumscribed depigmented macules and patches. Autoimmune reactions may play an important role in the pathogenesis of the disease. Mycophenolate mofetil is a drug that inhibits DNA
Farhad Handjani   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy